{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T20:05:00Z","timestamp":1772136300977,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T00:00:00Z","timestamp":1748044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T00:00:00Z","timestamp":1748044800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100031401","name":"UK Prevention Research Partnership","doi-asserted-by":"crossref","award":["MR\/S037578\/2"],"award-info":[{"award-number":["MR\/S037578\/2"]}],"id":[{"id":"10.13039\/100031401","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Medical Research Council","award":["MC\\_UU\\_00022\/5"],"award-info":[{"award-number":["MC\\_UU\\_00022\/5"]}]},{"name":"Medical Research Council","award":["MC\\_UU\\_00022\/5"],"award-info":[{"award-number":["MC\\_UU\\_00022\/5"]}]},{"DOI":"10.13039\/501100000269","name":"Economic and Social Research Council","doi-asserted-by":"crossref","award":["ES\/L011921\/1"],"award-info":[{"award-number":["ES\/L011921\/1"]}],"id":[{"id":"10.13039\/501100000269","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000269","name":"Economic and Social Research Council","doi-asserted-by":"crossref","award":["ES\/S007164\/1"],"award-info":[{"award-number":["ES\/S007164\/1"]}],"id":[{"id":"10.13039\/501100000269","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000269","name":"Economic and Social Research Council","doi-asserted-by":"crossref","award":["ES\/S007164\/1"],"award-info":[{"award-number":["ES\/S007164\/1"]}],"id":[{"id":"10.13039\/501100000269","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Prescribing of inhalers for asthma and chronic obstructive pulmonary disease is complicated due to multiple treatment pathways, diverse products, and variability in patients\u2019 needs and usage habits. Factors such as social deprivation, air quality, and differences in access to primary care influence both demand on respiratory medications and the rate and manner in which they are prescribed. Inhaler prescribing metrics are valuable for analysing temporal and geographic prescribing patterns across socio-economic groups, whether to identify areas with higher disease incidence or to assess problematic prescribing practices. Using data from OpenPrescribing.net, we estimate prescription items dispensed for different inhaler drugs in England at Lower Layer Super Output Area or \u2018neighbourhood\u2019 level. Generating metrics at small-area level enables analysis of the interactions between individuals, their environment, and the localised health system within which they are being treated. This approach complements a patient-centred clinical model that considers individual patient needs. To explore changes pre- and post- the March 2020 COVID-19 lockdown, we profile prescribing temporally and by neighbourhood-level deprivation, measured by the Index of Multiple Deprivation. We develop and apply seven prescribing measures informed by national clinical guidelines which facilitate contextual comparison of prescribing behaviour between neighbourhoods. We find inequalities in prescribing behaviour, with the most deprived neighbourhoods associated with higher rates of emergency or \u2019rescue\u2019 inhaler prescribing - a pattern that was interrupted during the March 2020 lockdown. Additionally, we find an increase in the prescribing of less environmentally friendly inhalers, contrary to national prescribing guidelines. This trend persisted until early 2022, when the trend began to reverse. Whilst many complex factors influence prescribing behaviour and safety, area-level deprivation appears to be an important dimension.<\/jats:p>","DOI":"10.1038\/s41598-025-02969-x","type":"journal-article","created":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T04:09:36Z","timestamp":1748059776000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Using OpenPrescribing.net to evaluate neighbourhood-level prescribing of inhalers for asthma and COPD"],"prefix":"10.1038","volume":"15","author":[{"given":"Thomas C.","family":"Richards","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"Heppenstall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel A.","family":"Oldroyd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Barr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger","family":"Beecham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,24]]},"reference":[{"key":"2969_CR1","unstructured":"NICE. Asthma Pathway (BTS, NICE, SIGN). https:\/\/www.nice.org.uk\/guidance\/ng244 (2024). Accessed: 2025-02-24."},{"key":"2969_CR2","unstructured":"Asthma UK. The Scale of Unsafe Prescribing in the UK Patient Safety Failures in Asthma Care. www.asthma.org.uk\/patient-safety (2014). Accessed: 2023-11-15."},{"key":"2969_CR3","unstructured":"NICE. Asthma: Inhaled corticosteroids. https:\/\/cks.nice.org.uk\/topics\/asthma\/prescribing-information\/inhaled-corticosteroids\/ (2023). Accessed: 2023-11-15."},{"key":"2969_CR4","unstructured":"British Thoracic Society. British guideline on the management of asthma. https:\/\/www.brit-thoracic.org.uk\/quality-improvement\/guidelines\/asthma\/ (2019). Accessed: 2023-11-15."},{"key":"2969_CR5","unstructured":"Noble, S. et al. The English Indices of Deprivation 2019 (2019)."},{"key":"2969_CR6","unstructured":"NHSBSA. Respiratory dashboard | NHSBSA. https:\/\/www.nhsbsa.nhs.uk\/access-our-data-products\/epact2\/dashboards-and-specifications\/respiratory-dashboard. Accessed: 2025-03-09."},{"key":"2969_CR7","unstructured":"OpenPrescribing.net. High dose inhaled corticosteroids | OpenPrescribing. https:\/\/openprescribing.net\/measure\/icsdose\/definition\/. Accessed: 2025-03-09."},{"key":"2969_CR8","unstructured":"OpenPrescribing.net. Short acting beta agonist inhalers | OpenPrescribing. https:\/\/openprescribing.net\/measure\/saba\/definition\/. Accessed: 2025-03-09."},{"key":"2969_CR9","unstructured":"SIGN and BTS. Sign 158. SIGN 158 British guideline on the management of asthma 1\u201328 (2019)."},{"key":"2969_CR10","unstructured":"OpenPrescribing.net. Environmental impact of inhalers - Prescribing of Metered Dose Inhaler (MDI) (excluding salbutamol) | OpenPrescribing. https:\/\/openprescribing.net\/measure\/environmental_inhalers\/definition\/. Accessed: 2025-03-14."},{"key":"2969_CR11","unstructured":"NHS Digital. Quality Outcomes Framework (QOF). https:\/\/digital.nhs.uk\/data-and-information\/data-tools-and-services\/data-services\/general-practice-data-hub\/quality-outcomes-framework-qof (2023). Accessed: 2023-11-15."},{"key":"2969_CR12","unstructured":"OpenPrescribing.net. Explore England\u2019s prescribing data. https:\/\/openprescribing.net\/ (2023). Accessed: 2023-11-15."},{"key":"2969_CR13","unstructured":"NHS Digital. Patients Registered at a GP Practice: Official statistics, Open data, Other reports and statistics. https:\/\/digital.nhs.uk\/data-and-information\/publications\/statistical\/patients-registered-at-a-gp-practice (2023). Accessed: 2023-11-15."},{"key":"2969_CR14","doi-asserted-by":"publisher","unstructured":"Jeswani, H.\u00a0K. & Azapagic, A. Life cycle environmental impacts of inhalers. J. Clean. Prod. 237, 117733. https:\/\/doi.org\/10.1016\/j.jclepro.2019.117733 (2019).","DOI":"10.1016\/j.jclepro.2019.117733"},{"key":"2969_CR15","doi-asserted-by":"publisher","unstructured":"Wilkinson, A. J.\u00a0K., Braggins, R., Steinbach, I. & Smith, J. Costs of switching to low global warming potential inhalers. an economic and carbon footprint analysis of nhs prescription data in england. BMJ Open 9. https:\/\/doi.org\/10.1136\/bmjopen-2018-028763 (2019).","DOI":"10.1136\/bmjopen-2018-028763"},{"key":"2969_CR16","doi-asserted-by":"crossref","unstructured":"Bloom, C., Wong, E., Hickman, K. & Elkin, S. Influence of the first wave of covid-19 on asthma inhaler prescriptions. NPJ Prim. Care Respir. Med. 31. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8617286\/ (2021).","DOI":"10.1038\/s41533-021-00260-w"},{"key":"2969_CR17","unstructured":"Royal College of Physicians. Why asthma still kills: National Review of Asthma Deaths. https:\/\/www.rcplondon.ac.uk\/projects\/outputs\/why-asthma-still-kills (2014). Accessed: 2023-11-15."},{"key":"2969_CR18","doi-asserted-by":"publisher","unstructured":"Sofianopoulou, E., Rushton, S., Diggle, P. & Pless-Mulloli, T. Association between respiratory prescribing, air pollution and deprivation, in primary health care. J. Public Health 35, 502\u2013509. https:\/\/doi.org\/10.1093\/pubmed\/fdt107 (2013).","DOI":"10.1093\/pubmed\/fdt107"},{"key":"2969_CR19","doi-asserted-by":"publisher","unstructured":"Tian, J., McGrogan, A. & Jones, M.\u00a0D. Temporal and geographical variation in low carbon inhaler dispensing in England, 2016 to 2021: an ecological study. J. R. Soc. Med. 116, 65\u201375. https:\/\/doi.org\/10.1177\/01410768221133566 (2023).","DOI":"10.1177\/01410768221133566"},{"key":"2969_CR20","unstructured":"NHS Innovation Service. Delivering a Net Zero Health Service. https:\/\/innovation.nhs.uk\/innovation-guides\/commissioning-and-adoption\/delivering-a-net-zero-health-service (2023). Accessed: 2023-11-15."},{"key":"2969_CR21","unstructured":"NHS England. The NHS Long Term Plan (2019). Accessed: 2025-03-16."},{"key":"2969_CR22","unstructured":"NHS England. Network contract directed enhanced service - investment and impact fund 2021\/22: Guidance. https:\/\/www.england.nhs.uk\/publication\/investment-and-impact-fund-2021-22-implementation-guidance\/ (2021). Accessed: 2025-05-07."},{"key":"2969_CR23","doi-asserted-by":"publisher","unstructured":"Malo, J. & Chan-Yeung, M. Agents causing occupational asthma. J. Allergy Clin. Immunol. 123, https:\/\/doi.org\/10.1016\/j.jaci.2008.09.010 (2009).","DOI":"10.1016\/j.jaci.2008.09.010"},{"key":"2969_CR24","doi-asserted-by":"publisher","unstructured":"Sullivan, K. & Thakur, N. Structural and social determinants of health in asthma in developed economies: a scoping review of literature published between 2014 and 2019. Curr. Allergy Asthma Rep. 20. https:\/\/doi.org\/10.1007\/s11882-020-0899-6 (2019).","DOI":"10.1007\/s11882-020-0899-6"},{"key":"2969_CR25","doi-asserted-by":"publisher","unstructured":"Mazumdar, S., Ghosh, S. & Mukherjee, S. Non-adherence to asthma medications: Relation to socio-economic status and asthma education. Eur. Respir. J. 46, OA4792. https:\/\/doi.org\/10.1183\/13993003.congress-2015.OA4792 (2015).","DOI":"10.1183\/13993003.congress-2015.OA4792"},{"key":"2969_CR26","doi-asserted-by":"publisher","unstructured":"Tiotiu, A. et al. Impact of air pollution on asthma outcomes. Int. J. Environ. Res. Public Health17. https:\/\/doi.org\/10.3390\/ijerph17176212 (2020).","DOI":"10.3390\/ijerph17176212"},{"key":"2969_CR27","doi-asserted-by":"publisher","unstructured":"Hart, J. The inverse care law. The Lancet 297, 405\u2013454. https:\/\/doi.org\/10.1016\/S0140-6736(71)92410-X (1971).","DOI":"10.1016\/S0140-6736(71)92410-X"},{"key":"2969_CR28","doi-asserted-by":"publisher","unstructured":"Fisher, R., Allen, L., Malhotra, A. & Alderwick, H. Tackling the inverse care law: Analysis of policies to improve general practice in deprived areas since 1990. https:\/\/doi.org\/10.37829\/HF-2022-P09 (2022).","DOI":"10.37829\/HF-2022-P09"},{"key":"2969_CR29","unstructured":"Office for National Statistics. Ons open geography portal. https:\/\/geoportal.statistics.gov.uk\/ (2024). Accessed: 2024-08-19."},{"key":"2969_CR30","unstructured":"Office for National Statistics. Ons census data service. https:\/\/www.ons.gov.uk\/census (2024). Accessed: 2024-08-19."},{"key":"2969_CR31","doi-asserted-by":"publisher","unstructured":"Woodcock, A. et al. Effects of switching from a metered dose inhaler to a dry powder inhaler on climate emissions and asthma control: post-hoc analysis. Thorax 77, 1187\u20131192. https:\/\/doi.org\/10.1136\/thoraxjnl-2021-218088 (2022).","DOI":"10.1136\/thoraxjnl-2021-218088"},{"key":"2969_CR32","doi-asserted-by":"publisher","unstructured":"Foster, J.\u00a0M. et al. A self-rating scale for patient-perceived side effects of inhaled corticosteroids. Respir. Res. 7, 131. https:\/\/doi.org\/10.1186\/1465-9921-7-131 (2006).","DOI":"10.1186\/1465-9921-7-131"},{"key":"2969_CR33","doi-asserted-by":"publisher","unstructured":"Bloom, C.\u00a0I., Yang, F., Hubbard, R., Majeed, A. & Wedzicha, J.\u00a0A. Association of Dose of Inhaled Corticosteroids and Frequency of Adverse Events. Am. J. Respir. Crit. Care Med. 211, 54\u201363. https:\/\/doi.org\/10.1164\/rccm.202402-0368oc (2024).","DOI":"10.1164\/rccm.202402-0368oc"},{"key":"2969_CR34","doi-asserted-by":"publisher","unstructured":"Bernal, J.\u00a0L., Cummins, S. & Gasparrini, A. Interrupted time series regression for the evaluation of public health interventions: a tutorial. Int. J. Epidemiol. 46, 348\u2013355. https:\/\/doi.org\/10.1093\/ije\/dyw098 (2016).","DOI":"10.1093\/ije\/dyw098"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02969-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02969-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02969-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T04:09:41Z","timestamp":1748059781000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02969-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,24]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2969"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-02969-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5394718\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,24]]},"assertion":[{"value":"5 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18089"}}